To assess the relevance of PLK1 as a potential target for cancer therapy, we analyzed its expression in A549 and NCI-H460 non-small cell lung cancer (NSCLC) cell lines (Figure 1). The gene discussed is PLK1; the disease is non-small cell lung carcinoma.